1.
theheartorg | Medscape
@theheartorg
Can you treat high #cholesterol in these challenging patient scenarios? #CME #CardioTwitter #MedEd
… twitter.com/i/web/status/1…
… twitter.com/i/web/status/1…
25 Mar 23
copy & paste +upvote -downvote ✅ Can you treat high #cholesterol in these challenging patient scenarios? #CME #CardioTwitter #MedEd
📍… https://t.co/zzcrXmMh7T
2.
theheartorg | Medscape
@theheartorg
Did you know that hypertrophic cardiomyopathy is estimated to affect 20 million people worldwide? Learn more abo… twitter.com/i/web/status/1…
19 Feb 23
copy & paste +upvote -downvote ➡️ Did you know that hypertrophic cardiomyopathy is estimated to affect 20 million people worldwide? Learn more abo… https://t.co/CDanBkWGZa
3.
4.
5.
6.
7.
theheartorg | Medscape
@theheartorg
@drjohnm discusses ERASE AF follow-up, recreational drugs and AF, etripamil, misuse of science, and diabetes as a… twitter.com/i/web/status/1…
28 Oct 22
copy & paste +upvote -downvote 🎧 @drjohnm discusses ERASE AF follow-up, recreational drugs and AF, etripamil, misuse of science, and diabetes as a… https://t.co/01TvkDCMYH
theheartorg | Medscape
@theheartorg
Did you know that approximately 40% of patients with #diabetes will develop chronic kidney disease at some stage… twitter.com/i/web/status/1…
25 Sep 22
copy & paste +upvote -downvote ❓ Did you know that approximately 40% of patients with #diabetes will develop chronic kidney disease at some stage… https://t.co/zBQYDddgE0
theheartorg | Medscape
@theheartorg
Tim Cook declared that Apple’s dive into the healthcare monitoring business will constitute the company's greates… twitter.com/i/web/status/1…
18 Aug 21
copy & paste +upvote -downvote Tim Cook declared that Apple’s dive into the healthcare monitoring business 💻 will constitute the company's greates… https://t.co/6FWo7WhE0z
theheartorg | Medscape
@theheartorg
#CVD and #T2Dm are modifiable risks for one another. Try your hand at patient engagement with this treatment sim… twitter.com/i/web/status/1…
30 Jul 21
copy & paste +upvote -downvote #CVD and #T2Dm are modifiable risks for one another. 🙌 Try your hand at patient engagement with this treatment sim… https://t.co/tUytH87i5X
theheartorg | Medscape
@theheartorg
Scientists stick their necks out to study the CV secrets of giraffes. ms.spr.ly/6014n38qj pic.twitter.com/m5zf035tFP
27 Jun 21
copy & paste +upvote -downvote Scientists stick their necks out to study the CV secrets of giraffes. https://t.co/n4LZU2PDsH 🦒 https://t.co/m5zf035tFP
8.
9.
10.
11.
theheartorg | Medscape
@theheartorg
ICYMI: The latest guidelines for using aspirin in CV prevention. ms.spr.ly/6017VN3r1 with @DLBHATTMD… twitter.com/i/web/status/1…
31 May 21
copy & paste +upvote -downvote 💊 ICYMI: The latest guidelines for using aspirin in CV prevention. https://t.co/4CHE4xgpin with @DLBHATTMD… https://t.co/2ed9Di2Xm6
theheartorg | Medscape
@theheartorg
Good news for coffee drinkers, based on 3 large observational trials. ms.spr.ly/6014p2beG
11 Feb 21
copy & paste +upvote -downvote ☕ Good news for coffee drinkers, based on 3 large observational trials. https://t.co/xibHO3WU1c
theheartorg | Medscape
@theheartorg
@drjohnm wants the FDA to say no to sacubitril/valsartan for HFpEF. ms.spr.ly/6013pWmB7 pic.twitter.com/9uw6ETsunG
19 Jan 21
copy & paste +upvote -downvote 🚫 @drjohnm wants the FDA to say no to sacubitril/valsartan for HFpEF. https://t.co/LUT3Y0ffvV https://t.co/9uw6ETsunG
theheartorg-Medscape
@theheartorg
#ESCCongress Poll: Who should start SGLT2 inhibitors in relevant patients?
Retweet of status by @theheartorg
30 Aug 20
copy & paste +upvote -downvote 👉 #ESCCongress Poll: Who should start SGLT2 inhibitors in relevant patients?
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13
copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊